Actinium Submits Pre-IND Meeting Request to the U.S. FDA for its Iomab-B Drug Candidate
January 26, 2015 at 07:07 AM EST
Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative ...
